Gilead Sciences is accused of giving kickbacks to healthcare organizations, government agencies, universities and community groups to boost sales of its hepatitis and HIV drugs, resulting in billions of dollars in excess government spending.
Gilead accused of funneling kickbacks to providers to boost sales
